Sign in →

Test Code Billings Clinic: 8083 Mayo: QFP Q Fever IgM and IgG, Titer, Serum

Reporting Name

Q Fever IgM/IgG, Titer, S

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Useful For

Diagnosis of Coxiella burnetii, the causative agent of Q fever

Method Name

Only orderable as a reflex. For more information see QFEVR / Q Fever Antibody Screen with Titer Reflex, Serum.

 

Indirect Immunofluorescence


Ordering Guidance


 



Specimen Required


Only orderable as a reflex. For more information see QFEVR / Q Fever Antibody Screen with Titer Reflex, Serum.

 

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Specimen Type

Serum

Specimen Minimum Volume

0.25 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  7 days

Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Gross icterus Reject

Reference Values

Only orderable as a reflex. For more information see QFEVR / Q Fever Antibody Screen with Titer Reflex, Serum.

 

Q fever phase I antibody, IgG

<1:16

 

Q fever phase II antibody, IgG

<1:16

 

Q fever phase I antibody, IgM

<1:16

 

Q fever phase II antibody, IgM

<1:16

 

Reference values apply to all ages.

Interpretation

A negative result argues against Coxiella burnetii infection. If early acute Q fever infection is suspected, collect a second specimen 2 to 3 weeks later and retest.

 

A negative result following a reactive C burnetii enzyme immunoassay screen suggests a falsely reactive screen. In cases of suspected acute C burnetii infection, repeat testing in 2 to 3 weeks is recommended.

 

Phase I antibody titers greater than or equal to phase II antibody titers are consistent with chronic infection or convalescent phase Q fever.

 

Phase II antibody titers greater than or equal to phase I antibody titers are consistent with acute/active infection.

 

In Q fever sera, it is common to see IgG titers of 1:128 or greater to both phase I and phase II antibody titers. IgG class antibody titers appear very early in the disease, reaching maximum phase II titers by week 8 and persisting at elevated titers for longer than a year. Phase I titers follow the same pattern, although at much lower levels, and may not be initially detected until convalescence.

 

In Q fever sera, it is common to see IgM titers of 1:64 or greater.

 

IgM class antibody titers appear very early in the disease, reaching maximum phase II titers by week 3 and declining to very low levels by week 14. Phase I titers follow the same pattern, although at much lower levels, and may not be initially detected until convalescence.

Day(s) Performed

Monday through Saturday

Report Available

Same day/1 to 3 days

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86638 x 4

LOINC Code Information

Test ID Test Order Name Order LOINC Value
QFP Q Fever IgM/IgG, Titer, S 77175-8

 

Result ID Test Result Name Result LOINC Value
80965 Q Fever Phase I Ab, IgG 34716-1
24011 Q Fever Phase II Ab, IgG In Process
81115 Q Fever Phase I Ab, IgM 9710-5
24009 Q Fever Phase II Ab, IgM 9711-3
24010 Interpretation 69048-7